Insider · CIK 0001352908
Michael R Hayden
Files at IONS (IONIS PHARMACEUTICALS INC), ABCL (AbCellera Biologics Inc.), ETNB (89bio, Inc.). First filing Dec 26, 2024, latest May 2, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | IONSbuy IONIS PHARMACEUTICALS INC | $478k 15,000 shares | +43% | +24% from low-26% from high | |
| 30Weak | IONSbuy IONIS PHARMACEUTICALS INC | $181k 5,000 shares | +17% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stock | -80,904 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stockindirect: See footnote | -103,978 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | UTender of shares Common Stockindirect: See footnote | -61,538 | - | - | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,647 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,933 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -22,730 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -27,400 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -45,150 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Oct 30, 2025 | ETNB 89bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -56,400 | $0.00 | $0 | 0 | Oct 30, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +4,079 | $0.00 | $0 | 54,298 | Jul 17, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -4,079 | $0.00 | $0 | 9,897 | Jul 17, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +11,518 | $0.00 | $0 | 11,518 | Jul 2, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +5,220 | $0.00 | $0 | 13,976 | Jul 2, 2025 |
| Jun 12, 2025 | ABCL AbCellera Biologics Inc. | AGrant or award Share option (right to buy)derivative | +238,864 | $0.00 | $0 | 899,843 | Jul 1, 2025 |
| May 1, 2025 | IONS IONIS PHARMACEUTICALS INC | POpen-market purchase Common Stock | +15,000 | $31.86 | $478k | 50,219 | May 2, 2025 |
| Feb 3, 2025 | ETNB 89bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +56,400 | $0.00 | $0 | 56,400 | Feb 5, 2025 |
| Dec 23, 2024 | IONS IONIS PHARMACEUTICALS INC | POpen-market purchase Common Stock | +2,500 | $36.20 | $90k | 32,719 | Dec 26, 2024 |
| Dec 23, 2024 | IONS IONIS PHARMACEUTICALS INC | POpen-market purchase Common Stock | +2,500 | $36.23 | $91k | 35,219 | Dec 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.